NCT05537701Active, not recruiting
Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)
Source: ClinicalTrials.gov · Last updated 16 Jan 2024
Brief summary (registry, in English)
The primary objective is to describe eosinophil infiltration in resected (early stage) NSCLC. Secondary objectives are: * to investigate the correlation of T-Eos and B-Eos in the aforementioned patient population; * to investigate the correlation between T-Eos and overall \& disease-free survival; * to investigate the localization of T-Eos (periphery vs. center of the tumor lesions).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 316 (actual)
- First submitted
- 8 Sept 2022
- Start date
- 3 Oct 2022
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- Centre Hospitalier Universitaire de Liege
- Diseases
- Lung cancer
- NCT number
- NCT05537701
What you commit to
- Study type: Observational
- Participants enrolled: 316
- From 3 Oct 2022 to the primary completion date, 31 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inclusion in a clinical study contraindicating enrollment in the present study
Who the study is looking for
- Resected, early stage NSCLC between 01-01-2015 and 30-04-2022 with available tumour tissue
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Liège Coordinator of this site? Confirm its status | Liège | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.